Status:
COMPLETED
Respiratory and Quadriceps Muscle Fatigability After an ICU Acquired Weakness
Lead Sponsor:
Groupe Hospitalier du Havre
Conditions:
ICU Acquired Weakness
Eligibility:
All Genders
18-80 years
Brief Summary
Muscle dysfunction can be lead to poor outcomes moreover ICU muscle weakness recovery are not correctly described. The investigators aimed to assess the ability for quadriceps or respiratory muscles ...
Eligibility Criteria
Inclusion
- Mechanically ventilated at least at 24 Hours
- Maximal inspiratory pressure \< 30 centimeter of water
- MRC score \< 48/60
Exclusion
- Age \< 18 years
- Patients with neurological pathology or pre existing neuromuscular dysfunction
- Patient unable to walk 50 meters before ICU admission
- Patient with a thoracic or abdominal surgery
- Inability to carry out maximal voluntary contraction
Key Trial Info
Start Date :
June 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05396066
Start Date
June 15 2022
End Date
February 1 2024
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier du Havre
Montivilliers, Groupe Hospitalier Du Havre, France, 76290